期刊文献+

无锡市以人乳头瘤病毒DNA分型检测为基础的宫颈癌筛查绩效评价 被引量:5

Evaluation on cervical cancer screening performance in Wuxi city based on HPV DNA genotyping detection
原文传递
导出
摘要 目的针对无锡地区以人乳头瘤病毒(human papillomavirus,HPV)DNA分型检测为基础的宫颈癌筛查进行卫生经济学评价。方法运用Markov模型对2013年无锡市185 328名妇女以HPV基因分型检测为基础的宫颈癌筛查数据进行预测,预测之后10年的情况,以自然发展组为对照,计算终身筛查一次、每3年筛查一次、每5年筛查一次的队列分布,结合筛查费用及治疗费用分析评价成本效果、成本效益和成本效用等卫生经济学指标。结果终身筛查一次、每3年筛查一次和每5年筛查一次与自然发展相比,10年可以累计增加的质量调整生命年(quality adjusted life year,QALY),分别是481.75、2 865.35、1 949.84;CIN2以上患病率分别降低了4.90%、42.26%、28.06%;死亡率分别降低了1.13%、2.03%、1.59%;每挽救一个生命年的成本分别是30 991.30元、70 612.81元、55 654.18元;每挽救1个质量调整生命年的成本分别是19 234.9元、11 311.5元、10 817.8元;每投入1个单位成本所获得的效益分别是3.04、5.27、5.55。结论每5年筛查一次的方案比较适合无锡这种中小城市的宫颈癌防控。 Objective To evaluate the cervical cancer screening performance in Wuxi city based on human papillomavirus(HPV)DNA genotyping detection. Methods The Markov model was adopted to predict situations in the next ten years according to the cervical cancer screening data collected from 185 328 women in Wuxi in 2013 and processed based on HPV genotyping detection.Using unscreened women as control,data for women being screened once in a life time,once every three years and once every five years were individually calculated.In combination with screening and treatment expenses,health economics index such as cost effectiveness,cost benefit and cost utility were analyzed and compared. Results Compared with control group,screening once in a life time,once every three years and once every five years could add up 481.75,2 865.35 and 1 949.84 quality adjusted life years(QALYs),respectively.The prevalence of CIN2 and above decreased by 4.90%,42.26%,28.06% and mortality reduced by 1.13%,2.03%,1.59%,respectively.The costs of a life year saved were 30 991.30,70 612.81 and 55 654.18 RMB for each screening strategies above.The costs per QALY were 19 234.9for screening once in a life time,11 311.5for screening once every three years and 10 817.8for screening once every five years.Meanwhile,the benefits achieved from each unit cost invested were 3.04,5.27 and 5.55,respectively. Conclusions Considering the health economics effectiveness,it is suggested that every five years screening interval based on HPV DNA genotyping detection is suitable to a small and medium-sized city like Wuxi.
出处 《中国预防医学杂志》 CAS 2015年第11期848-853,共6页 Chinese Preventive Medicine
基金 国家自然科学基金青年科学基金项目(81202043) 南京市科技计划项目(2013创基025)
关键词 HPV DNA分型检测 宫颈癌筛查 MARKOV模型 卫生经济学评价 HPV DNA genotyping detection Cervical cancer screening Markov model Health economics evaluation
  • 相关文献

参考文献6

二级参考文献59

  • 1王春芳,郑莹,邱永莉,顾凯,鲍萍萍,向咏梅,彭鹏,吴春晓,金凡.上海市2002—2005年宫颈癌病理与预后分析[J].上海预防医学,2007,19(4):149-151. 被引量:15
  • 2Sonnenberg FA,Beck JR.Markov models in medical decision making:A practical guide.Medical Decision Making,1993,13:322-350. 被引量:1
  • 3[1]Furlong W, Feeny D, Torrance G, et al. Guide to design and development of health - state utility ins instrumentation: Center for Health Eeonomics and Policy Analysis Working Paper. Hamilton, Ontario, Canada, McMaster University, 1990. 被引量:1
  • 4[2]FA Sonnenberg, JR Robert. Markov Models in Medical Decision Making: A practical Guide. Med Decis Making, 1993,13: 322. 被引量:1
  • 5[3]Briggs A, Sculpher Mark. An Introduction to Markov Modelling for Economic Evaluation. Pharmacoeconomics,1998,13(4) :397. 被引量:1
  • 6[4]D Naimark, MD Krahn, G Naglie, et al. Primer on Medical Decission Analysis: Part 5 - Working with Markvo Processes. Med Decis Making,1997,17:152. 被引量:1
  • 7孙振球,主编.医学统计学.人民卫生出版社,2006,415-438. 被引量:1
  • 8刘启贵,张福良,主编.SPSS for Windows.大连出版社,1999,70-83. 被引量:1
  • 9Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008. Cancer incidence and mortality worldwide: IARC Cancer- Base No. 10 [DB/OL]. http://globocan. iarc.fr, 2010. 被引量:1
  • 10Gustafsson L, Ponten J, Zack M, et al. International incidence rates of in- vasive cervical cancer after introduction of cytological screening[J]. Cancer Caus- es Control, 1997, 8(5): 755-763. 被引量:1

共引文献133

同被引文献50

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部